Medifast Inc (NYSE:MED)
$ 24.67 0.28 (1.15%) Market Cap: 269.82 Mil Enterprise Value: 130.90 Mil PE Ratio: 4.01 PB Ratio: 1.28 GF Score: 72/100

Medifast Inc at ICR Conference Transcript

Jan 13, 2020 / 06:00PM GMT
Release Date Price: $112.63 (+2.79%)
Unidentified Analyst

Good afternoon, everyone, and welcome back from lunch. Next up, we have Medifast. And here to present today is CEO, Dan Chard.

(presentation)

Daniel R. Chard
Medifast, Inc. - CEO & Director

Good afternoon. It's great to be with you this afternoon. What you just saw was a reel of our PR campaigns that have taken place in the 12 -- in the past 12-plus months. Why this is important is not just because it's part of our brand-building campaign, but this is also what our coaches throughout the country and Asia are using to [share] the OPTAVIA message.

So for those of you who are new to our story, I'll be sharing with you a little bit about who Medifast is, what we do, what we've been doing for the last 3 years, which is a period of time when we have changed our model, focused completely on coaches, and then lastly, talk about what our plans for growth are.

So first of all, Medifast at a glance. So if you think about the company, historically, we've been a company that's focused on 4 different channels. At the beginning

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot